Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
Vaccine
|
August 19, 2004
10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy
Kiran Katoch, Vishwa Mohan Katoch, Mohan Natrajan, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association
|
June 1, 1989
Results of a modified WHO regimen in highly bacilliferous BL/LL patients
K Katoch, G Ramu, U Ramanathan, et al.
The Journal of General Physiology
|
August 8, 2018
The voltage-gated sodium channel pore exhibits conformational flexibility during slow inactivation
Soumili Chatterjee, Rajan Vyas, Sreevatsa V Chalamalasetti, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association
|
June 1, 1995
Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy
K Katoch, V M Katoch, M Natrajan, et al.
Chemotherapy Research and Practice
|
March 1, 2016
The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India
Govind Babu, Smitha Carol Saldanha, Lakshmaiah Kuntegowdanahalli Chinnagiriyappa, et al.
The Journal of General Physiology
|
September 30, 2015
A chimeric prokaryotic pentameric ligand-gated channel reveals distinct pathways of activation
Nicolaus Schmandt, Phanindra Velisetty, Sreevatsa V Chalamalasetti, et al.
Indian Journal of Leprosy
|
April 6, 1999
Comparative leprosy vaccine trial in south India
M D Gupte, R S Vallishayee, D S Anantharaman, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
Vaccine
|
August 19, 2004
10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy
Kiran Katoch, Vishwa Mohan Katoch, Mohan Natrajan, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association
|
June 1, 1989
Results of a modified WHO regimen in highly bacilliferous BL/LL patients
K Katoch, G Ramu, U Ramanathan, et al.
The Journal of General Physiology
|
August 8, 2018
The voltage-gated sodium channel pore exhibits conformational flexibility during slow inactivation
Soumili Chatterjee, Rajan Vyas, Sreevatsa V Chalamalasetti, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association
|
June 1, 1995
Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy
K Katoch, V M Katoch, M Natrajan, et al.
Chemotherapy Research and Practice
|
March 1, 2016
The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India
Govind Babu, Smitha Carol Saldanha, Lakshmaiah Kuntegowdanahalli Chinnagiriyappa, et al.
The Journal of General Physiology
|
September 30, 2015
A chimeric prokaryotic pentameric ligand-gated channel reveals distinct pathways of activation
Nicolaus Schmandt, Phanindra Velisetty, Sreevatsa V Chalamalasetti, et al.
Indian Journal of Leprosy
|
April 6, 1999
Comparative leprosy vaccine trial in south India
M D Gupte, R S Vallishayee, D S Anantharaman, et al.
Page
of 6